chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tachycardia; Palpitation; Full body flush; Full body feeling hot; This is a spontaneous report from a non-contactable nurse. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Caller stated, "So, she said that this person, (Name) had the same effect that she had and I already reported her side effects and basically they had the full body flush with the tachycardia, palpitations and it lasted for about 5 minutes and then went away. It said, it felt like a full body flush and she said it reminds me when you get those IVs that make your full body feeling hot, so she said it's full body flush, tachycardia, palpitation and then after 5 minutes, it went away and they were all fine." The outcome of events was recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
I Approx 3 hours after receiving the vaccine I began feeling tingling/numbness in my left foot lower leg. Tingling spread to both feet & hands arms lower legs. Slight swelling of tongue/ throat but I could swallow and breathe.   It is now 16 hours since I received the vaccine and I?m still experiencing tingling / numbness and slight tongue/ throat swelling. I have decided to take Benadryl to see if it helps.
reflexive sympathetic disorder; I have tremendous pain in my right arm where i was vaccinated and i have lost basic use of my right arm. I'm loosing the use of my arm since march I'm in terrible pain and I've given it plenty time.; i have lost basic use of my right arm. I'm loosing the use of my arm since Mar I'm in terrible pain and I've given it plenty time.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm right, administration date Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COMPLEX REGIONAL PAIN SYNDROME (non-serious) with onset 2021, outcome "unknown", described as "reflexive sympathetic disorder"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "not recovered", described as "I have tremendous pain in my right arm where i was vaccinated and i have lost basic use of my right arm. I'm loosing the use of my arm since march I'm in terrible pain and I've given it plenty time."; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2021, outcome "not recovered", described as "i have lost basic use of my right arm. I'm loosing the use of my arm since Mar I'm in terrible pain and I've given it plenty time.". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt had adverse reaction to pneumo 23 vaccine. Pt returned to our office the next day after receiving vaccine with left arm redness, swelling & pain. Pt treated with antibotics Amoxicillin 500mg x10days, Loratadine 10mg once daily and Ibuprofen 600mg prn pain. Pt returned 1 week later on 07/05/19 Dr. reassessed patient-cellulitis resolved.
Swollen lymph nodes in the area between my neck and shoulder, swollen lymph nodes in my left armpit, swollen lymph nodes in my left breast, swollen lymph nodes in my left groin.
This spontaneous report as received from a health care worker refers to an unspecified number of patients of unknown ages and genders. Information regarding the patients' pertinent medical history, drug reaction/allergies and concomitant medications was not reported. On an unspecified dates, the patients were vaccinated with improperly stored M-M-R II (lot number and expiration date were unspecified, dose, frequency and route of administration were not reported). No adverse events were reported. There was no product quality complaint. This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax 1996 & pt devel measles;f/u from same MD indicated that pt could not verify whether pt recv any MMR;
This spontaneous report was received from a registered nurse and refers to a 5 year old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 09-DEC-2016, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(manufacturer unknown), lot # M015735 with expiration date of 30-MAR-2018 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 73 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1705USA014053:
BOIL AND RASH ON LEFT ARM BOIL ON BUTTOCKS KNOT ON LEFT ELBOW AREA FACIAL RASH
At first it was a hard, swollen, and red lump that was hot to the touch at the injection site, that showed up the day after shot. Then over the course of 6 days, it got progressively worse. The hard red lump remained in the center of the upper arm, but redness, swelling, itchiness and inflammation spread out from the center lump. The reaction continues to spread farther away from the center, across my upper arm. I am feeling exhausted from my body constantly attacking the area.  It continues now, going on day 7 with no end in sight.
1wk p/vax pt began running T105;ran 103-105 for 2 days, had vomitting, was irritable & had mucous in eyes;seen by MD;
Immunizations on 10/02/2006 symptoms of bloody stools 12/04 surgical reduction of intussusception 12/04.  1/22/07 Received medical records from hospital which reveal patient admitted 12/4/-12/7/06 after having had bright red bloody diaper & was fussy prior to being seen in ER on 12/4/06.  GYN & surgical consults done to r/o vaginal bleeding.  US showed IS.  Air enema attempt to reduce intussusception was unsuccessful & was taken to OR whre it was reduced w/o difficulty. Continued to improve & was d/c to home w/o complications.  FINAL DX: Intussusception, surgically reduced.
This case was reported by a pharmacist and described the occurrence of not responding to therapy in a male subject of unspecified age who was vaccinated with HAVRIX (GlaxoSmithKline). On 13 October 2013 and 17 April 2012 the subject received 1st dose and 2nd dose of HAVRIX (unknown). On 24 May 2012, 37 days after vaccination with 2nd dose of HAVRIX, 7 months after vaccination with 1st dose of HAVRIX, the subject experienced not responding to therapy. The subject had a titer performed on 24 May 2012 and showed non reactive. The healthcare professional reported several subjects did not respond to Hepatitis A vaccine; seven with HAVRIX and three with TWINRIX. For the other subjects please see OCEANS cases A0994236A, A0994238A, A0994239A, A0994241A - A0994246A.
Initial report received on 07 March 2008 from a physician. A 27-year-old female patient, who had no known allergies, and whose past medical history included the current pregnancy and one previous pregnancy (outcome not reported), had received a first, intramuscular, left deltoid dose of ADACEL (lot # C2769AA), on 14 February 2008. At the time of this report, the patient was in her first trimester, and had not experienced any adverse events since her vaccination with ADACEL on 14 February 2008. The date of the patient's last menstrual period and expected date of delivery were not provided. No other relevant medically significant information was provided. Follow-up information received on 08 July 2008 from the original reporter who is a physician. The patient has past medical history of migraines and depression. On an unspecified date, the patient presented to the hospital emergency department with syncope and headache. She was treated with Compazine and found to be pregnant. At that time, the patient had a nine month old baby at home and was breast feeding. The patient had no history of alcohol or tobacco use. On 29 January 2008, the patient had an ultrasound that estimated the current pregnancy to be at six weeks gestation. From this new information this case was upgraded to serious.
Information has been received from a nurse concerning her daughter who is 18 years old. The patient's historical medications included unspecified Hepatitis A vaccination received 2 weeks prior to GARDASIL and MENACTRA received at unspecified time prior to GARDASIL. The patient was allergic to Penicillin since unspecified time in early childhood. On an unknown date in August 2015, she was vaccinated with first dose of GARDASIL (dosing details were not reported) (lot # K010215, expiration date unknown). Concomitant therapies included ATIVAN. The first day after GARDASIL administration, patient had an episode of heart racing with heart rate to 180 beats and she became incoherent, had a severe decrease in blood pressure, and passed out in the ambulance on the way to the emergency room. The reporter stated that the same events happened again on the second and third days after GARDASIL, and on the third day patient experienced tonic-clonic jerking motions and was then admitted to an unnamed hospital. The patient's Magnetic resonance imaging (MRI) and electroencephalogram (EEG) results were "normal" according to reporter. Two weeks after the GARDASIL vaccination, patient had an episode where she could not breathe. At unspecified times after that, patient began to experience severe constipation, and sometimes she did not move her bowels for as long as 6 days, she had joint pain and episodes of rapid heartbeat. She was monitored at home with a portable Bolter-type cardiac monitor, which showed ventricular tachycardia to 203 beats during sleep, on the monitor. She was started on metoprolol at an unknown dose after the episodes of tachycardia began. Approximately in September 2015, she began to experience a persistent tic in her left arm beginning. On an unknown date in November 2015, she had episodes of low blood pressure and had a positive tilt table test. On an unknown date, she experienced episodes of rib and back pain, severe menstrual pain, she was passing large clots during menses and had frequent episodes of anxiety. She had a total of 12 ER visits, and missed her first year of college due to her frequent symptoms. At the time of the report if she gets "any type of virus", she gets leg weakness and pain in her joints. The outcome of the events were unknown. The reporter did not provide the relatedness of the events with GARDASIL. There was no product quality complaint reported. Upon internal review the events "Loss of consciousness, Tonic clonic movements and ventricular tachycardia" were determined to be medically significant. Additional information has been requested.
A few hours after vaccination, the patient reported increased pain in her right arm.  Later the same night, she noticed decreased range of motion of her right arm with radiation of the pain to her ride side (rib cage) with numbness and tingling of her arm.  The following morning, she experienced dizziness upon waking and fainted.  She also reported nausea, but no vomiting.  She currently is reporting dizziness only when she moves.  The pain is a constant dull ache that increases with touch.
Patient received vaccine and ended up going to the doctor because it turned red and had welts. charge nurse called us to inform us it looked like it was given subq just from the anatomical site. we did not hear from the patient as of yet about the adverse reaction, this report is filled based off of information given to us by the head nurse.
This spontaneous report as received from a female consumer refers to herself. The patient was vaccinated with ZOSTAVAX (lot # was not reported) and had a headache the day of the shot and redness and swelling at the injection site. No other co-suspects were reported. No concomitant medications were reported. The outcome and relationship were not reported. Additional information is not expected.
The morning after the vaccine, I experienced diarrhea.  I don't think it was from anything I ate the night or day before.  There were no stomach cramps or issues prior, just the sudden urge to expel.   There are no lingering effects or discomforts.  No discomforts at all.
Initial unsolicited report received from a nurse on 20 October 2015. This case linked with 2015SA169857, 2015SA169859, 2015SA169865 and 2015SA169870 (same batch number). This case involves a female patient (age not reported) who was vaccinated with a single dose of Fluzone QIV (batch number U5321BA, Expiry date 30 June 2016, dose, dose in series, route and site of administration was not reported) on 16 October 2015. Medical history and concomitant medications were not reported. On unspecified date, following the vaccination, the patient developed rash and localized reaction. Lab data and corrective treatments were not reported. Outcome of events was not reported. List of documents held by sender: none. Followup information received from nurse on 12 January 2016. This case involves 57-year-old patient. It was reported that, the patient had not experienced any adverse event after flu vaccination previously. The patient had heart catheter with stent in October 2014, allergy to Simcor, penicillin and raw tomato, type 2 diabetes, weight loss, chemotherapy, peripheral neuropathy, hyperlipidemia, positive for myalgia. The patient's previous medications includes Lopressor, monopril, aspirin, Effient, Byetta, Zetia, Crestor, metformin. On 16 October 2015, same day following the vaccination, the patient had experienced edema and pink right deltoid, chest pain, severe arm pain and swelling. The right arm had pink area in deltoid region. Laboratory data includes blood pressure- 115/70 mm/hg, body temperature- 36 degree Celsius, body mass index- 24.50 kg/m2 oxygen saturation -94 percent. The patient had received ibuprofen and heat or cold topical treatment as corrective treatment. The patient was recovering from events chest pain, severe arm pain and swelling.
Received 1st Covid Vaccination (Moderna) withing 45 minutes my right ear got very warm and red and my face was tingling/itching. By the next day it settled down. 5 days later right side of my face started feeling numb/tingling. Area of right jowl near ear was hard. Right nostril was numb face feels like coming out of dental anesthetic after procedure. Drooling and very slight droop on right side. Went to primary physician, did exam for bells palsey (given prednisone and acyclovar consulted neurologist was told not to get the second vaccine. Scheduled for brain MRI.
Information has been received from a consumer referring to her daughter, a female patient of unknown age. No relevant medical history or concurrent conditions were reported. On an unknown date the patient was vaccinated with MMR II (strength, dose, frequency, lot# and expiration date not reported) via subcutaneous to against MMR II. On an unknown date the patient experienced adverse event. The outcome of the event was unknown. Causality assessment was not reported. Additional information is not expected due to lack of contact information.
Redness, burning, discharge and swelling to the left eye. Suspected conjunctivitis.; Redness, burning, discharge and swelling to the left eye. Suspected conjunctivitis.; Redness, burning, discharge and swelling to the left eye. Suspected conjunctivitis.; Redness, burning, discharge and swelling to the left eye. Suspected conjunctivitis.; Redness, burning, discharge and swelling to the left eye. Suspected conjunctivitis.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 22:00, the patient experienced redness, burning, discharge and swelling to the left eye. The patient suspected conjunctivitis. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events redness, burning, discharge and swelling to the left eye, suspected conjunctivitis was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2022 at 2:03 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Mar-2022 at 2:03 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   No treatment information was provided. Vaccine administration time 14:03:51 The patient was administered booster dose that went into 2 to 8 Celsius thaw state on or above 24-Dec -2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.   This case was linked to MOD-2022-542869 (Patient Link).
Pain in right and left arm, redness, swelling in wrists, migraine, nausea,
Info has been received from a health professional concerning 2 adolescent pts who in 1997 were vaccinated with doses of varicella virus vaccine live. "Recently", in approximately, January, 2005, the pts experienced mild cases of chicken pox. The children were recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other info was available. Follow-up info was received regarding one of the pts, an 8 year old white male who on 12/9/97 was vaccinated with a dose of varicella virus vaccine live. It was reported that on 1/19/05, the child developed "typical dewdrop on rose petal type lesions in various stages of development". There were approximately 15 lesions. The pt recovered. No additional info is expected.
Patient stated arm was sore, and a larger than expected rash developed on the arm near injection site. Patient reported reaction 5 days after vaccination and still had redness that was warm to the touch about 4 by 2 inches below injection site but above elbow on left arm. No longer itches but arm still achy. I advised to call Dr if not improved by 8/4/21
Blisters on stomach. Red face and skin hot. Slight fever. Skin itchy. Took BENADRYL for itching & redness.
As part of a CDC protocol, he was given a smallpox vaccine on 3/6/02, along with a number of co-workers. He had what seemed to be a pretty good take at that time. He had no problems and had complete resolution of what limited systemic complaints he had, as well as complete resolution of the eschar at the inoculation site. He has been well until about a week ago, at which time, he noticed a blister directly overlying the site of the prior inoculation. He recalls no trauma associated with that blister. A day or so after he noted the blister, it resolved, and he does not recall any drainage associated with resolution, but did notice some eschar formation, which is now nearly resolved. He has had no systemic complaints of any king, nor has he had any lesions anywhere else on the body. He is here for follow-up as he thought it was probably prudent to at least have this looked at, given that this is part of a study involving the CDC and given that it is a rather unusual occurrence. I am not aware of any other co-workers with similar problems. We have had no work from anyone, and this employee does not know of anyone else with a similar problem. He is alert, oriented and comfortable. There is an area of erythema that is well circumscribed and appears to be directly overlying the prior injection site. This is just less than a centimeter in diameter. This is a small area of eschar just to the posterior aspect of midline of the erythematous area. There is no induration. There is no blistering and there is no discharge or drainage. There is no left inguinal adenopathy. Although there are a number of abrasions over the forearms of both arms related to minor trauma 3 days ago, there are no other skin lesions noted. I think what might have happened is that there may have been a small, walled off amount of inoculant that may have ruptured and subsequently formed eschar. Since this is not associated with any symptoms or other skin lesions and appears to be nearly resolved now, I do not think he will have any sequelae or any associated problems. I do not think there is any risk of the almost nearly-healed lesion being contagious at this point.
Submassive PE 5-6 weeks after the 2nd dose of COVID Moderna vaccine, no other pre-disposing factors other than hx of DVT after a surgery.
scratchy throat, racing heart, chest tightness Narrative: Patient received a covid vaccination and began experiencing throat  scratchiness, hoarse throat, tachycardia, chest tightness. She was brought to the urgent care. In the UCC she received epinephrine IM, Solu-Medrol 125mg IV, Pepcid 20mg IV, Benadryl 50 mg IV with good results. She was tachycardia but it was a sinus tachycardia without any acute ST OR T-wave changes. The patient was sent to emergency department.
This case was reported by a pharmacist via sales rep and described the occurrence of pain in arm in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows; The age at vaccination was not reported. The patient experienced severe sore arm. This case has been linked to US2018077610, US2018GSK080935, US2018GSK186351 and US2018GSK186361, reported by the same reporter.
Redness around injection site about 2 inches x 6 inches. No itching or pain, but site is warm to the touch.